Limited Availability of Lupus Laboratory Tests, Such As ANA, in Developing Nations Affects Global Usefulness of Criteria and Clinical Trials

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a...
6-Nov-2019 12:00 PM EST Add to Favorites

Low-Dose Oral Prednisolone Substantially Improves Pain and Function in Hand Osteoarthritis

Research presented at the 2019 ACR/ARP Annual Meeting found that a six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation in patients with painful hand osteoarthritis.
6-Nov-2019 12:00 PM EST Add to Favorites

Babies Exposed to TNF Inhibitors or Tofacitinib in Utero Experience Very Few Serious Infections

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children...
6-Nov-2019 12:00 PM EST Add to Favorites

Ultrasound to Guide Treatment Strategy Not Beneficial in Early RA

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, a treatment strategy guided by ultrasound information use does not appear to provide better treatment decisions in patients with early rheumatoid arthritis.
6-Nov-2019 12:00 PM EST Add to Favorites

Study Finds that Psoriasis Onset Determines if Psoriatic Arthritis Patients Develop Arthritis or Psoriasis First

In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.
6-Nov-2019 12:00 PM EST Add to Favorites

Down Syndrome Arthropathy Diagnosis Typically Delayed a Year, Optimal Treatments Still Unclear

A new study found that patients with Down syndrome arthropathy continue to have an approximate year-long delay in diagnosis from the onset of their symptoms, and that optimal therapy for this condition remains unclear (Abstract # 2722).
6-Nov-2019 12:00 PM EST Add to Favorites

Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact

New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016.
6-Nov-2019 12:00 PM EST Add to Favorites

Children with Down Syndrome at Increased Risk for Associated Inflammatory, Erosive Arthritis

A new study finds that children with Down syndrome are at an increased risk of an associated form of arthritis.
6-Nov-2019 12:00 PM EST Add to Favorites

see all news